Explaining Odds Ratios as Conditional Risk Ratios
- 期刊名称Journal of Clinical Epidemiology
- 作者Hoppe, Fred M.; Hoppe, Daniel J.; Walter, Stephen D.
- 印刷ISSN0895-4356
- 文件大小492.63KB
- 发表时间2017-11
- DOI10.1016/j.jclinepi.2017.10.009
A Synthetic Serine Protease Inhibitor, Nafamostat Mesilate, Is a Drug Potentially Applicable to the Treatment of Ebola Virus DiseaseNishimura, Hidekazu; Yamaya, Mutsuo · The Tohoku Journal of Experimental Medicine · 2015
Nafamostat mesilate, a serine protease inhibitor, suppresses lipopolysaccharide-induced nitric oxide synthesis and apoptosis in cultured human trophoblastsMikiya Nakatsuka; Kazuo Asagiri; Soichi Noguchi; Toshihiro Habara; Takafumi Kudo · 2000
Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthmaChen, Chih-Lung; Wang, Shulhn-Der; Zeng, Zhao-Ying; Lin, Kuo-Juei; Kao, Shung-Te; Tani, Thoru; Yu, Chun-Keung; Wang, Jiu-Yao · Journal of Allergy and Clinical Immunology · 2006
Nafamostat Mesilate, a Potent Serine Protease Inhibitor, Inhibits Airway Eosinophilic Inflammation and Airway Epithelial Remodeling in a Murine Model of Allergic AsthmaIshizaki, Masayuki; Tanaka, Hiroyuki; Kajiwara, Daisuke; Toyohara, Tatsuyuki; Wakahara, Keiko; Inagaki, Naoki; Nagai, Hiroichi · Journal of Pharmacological Sciences · 2008
Editorial BoardInternational Immunopharmacology · 2014
Editorial BoardInternational Immunopharmacology · 2013
Editorial BoardInternational Immunopharmacology · 2014
2nd sulfur mustard special issueGhazanfari, Tooba; Hassan, Zuhair M. · International Immunopharmacology · 2013
Thanking ReviewersInternational Immunopharmacology · 2014
Editorial BoardInternational Immunopharmacology · 2013
Editorial BoardInternational Immunopharmacology · 2013
Editorial BoardInternational Immunopharmacology · 2013